Orphazyme A S Is A Biopharmaceutical Company Based In Copenhagendenmarkwith Operations In The U Sand Switzerlandfounded In 2009The Company Focused On Developing Treatments For Neurodegenerative Rare Diseases Linked To Protein Misfolding And Aggregationits Primary Area Of Research Involved The Heat Shock Proteinhspresponse The Company S Lead Candidatearimoclomolwas In Clinical Development For Several Orphan Diseasesincluding Niemann Pick Disease Type Camyotrophic Lateral Sclerosissporadic Inclusion Body Myositisand Gaucher Diseasearimoclomol Aimed To Enhance The Body S Natural Response To Stress By Amplifying Hsps To Combat These Conditions In 2022Orphazyme Underwent Significant Changesresulting In The Sale Of Its Assets And Business Activities To Kempharm Denmark A Sthis Followed Challenges In Obtaining Marketing Authorization For Arimoclomolas Of December 2022The Company Had Reduced Its Workforce Significantly
No conferences found for this company.
| Company Name | Orphazyme As |
| Country |
Denmark
|
| Address | N/A |
| Telephone | N/A |
| N/A |
